Porcine pancreatic ductal epithelial cells transformed with KRASG12D and SV40T are tumorigenic

[1]  Rashmi Kumar,et al.  Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology. , 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

[2]  E. Ziv,et al.  Induction and characterization of pancreatic cancer in a transgenic pig model , 2020, PloS one.

[3]  M. Hollingsworth,et al.  Induction of pancreatic neoplasia in the KRAS/TP53 Oncopig , 2020, bioRxiv.

[4]  Caroline M. Li,et al.  Molecular Targeting of Cancer-Associated PCNA Interactions in Pancreatic Ductal Adenocarcinoma Using a Cell-Penetrating Peptide , 2020, Molecular therapy oncolytics.

[5]  M. Carlson,et al.  Porcine Models of Pancreatic Cancer , 2019, Front. Oncol..

[6]  M. Weniger,et al.  The Extracellular Matrix and Pancreatic Cancer: A Complex Relationship , 2018, Cancers.

[7]  L. Rund,et al.  KRASG12D and TP53R167H Cooperate to Induce Pancreatic Ductal Adenocarcinoma in Sus scrofa Pigs , 2018, Scientific Reports.

[8]  L. Rund,et al.  KRASG12D and TP53R167H Cooperate to Induce Pancreatic Ductal Adenocarcinoma in Sus scrofa Pigs , 2018, Scientific Reports.

[9]  Yupei Zhao,et al.  E‑cadherin is downregulated by microenvironmental changes in pancreatic cancer and induces EMT. , 2018, Oncology reports.

[10]  Anas M. Saad,et al.  Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study , 2018, BMC cancer.

[11]  Alexander Kind,et al.  Genetically engineered pigs as models for human disease , 2018, Disease Models & Mechanisms.

[12]  K. Schachtschneider,et al.  The Oncopig Cancer Model as a Complementary Tool for Phenotypic Drug Discovery , 2017, Front. Pharmacol..

[13]  Honghui Li,et al.  Efficient generation of P53 biallelic knockout Diannan miniature pigs via TALENs and somatic cell nuclear transfer , 2017, Journal of Translational Medicine.

[14]  L. Scobie,et al.  Inactivation of porcine endogenous retrovirus in pigs using CRISPR‐Cas9, editorial commentary , 2017, Xenotransplantation.

[15]  D. Meyerholz,et al.  Genetic ataxia telangiectasia porcine model phenocopies the multisystemic features of the human disease. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[16]  Y. Liu,et al.  A genetically inducible porcine model of intestinal cancer , 2017, Molecular oncology.

[17]  S. Bauersachs,et al.  Altered microRNA profiles during early colon adenoma progression in a porcine model of familial adenomatous polyposis , 2017, Oncotarget.

[18]  Yong Wang,et al.  Inactivation of porcine endogenous retrovirus in pigs using CRISPR-Cas9 , 2017, Science.

[19]  K. Schachtschneider,et al.  The Oncopig Cancer Model: An Innovative Large Animal Translational Oncology Platform , 2017, Front. Oncol..

[20]  H. Dawson,et al.  The porcine translational research database: a manually curated, genomics and proteomics-based research resource , 2017, BMC Genomics.

[21]  L. Rund,et al.  A validated, transitional and translational porcine model of hepatocellular carcinoma , 2017, Oncotarget.

[22]  H. Dawson,et al.  An in-depth comparison of the porcine, murine and human inflammasomes; lessons from the porcine genome and transcriptome. , 2017, Veterinary microbiology.

[23]  A. Marinis,et al.  Prognostic Evaluation of Vimentin Expression in Correlation with Ki67 and CD44 in Surgically Resected Pancreatic Ductal Adenocarcinoma , 2017, Gastroenterology research and practice.

[24]  Laurence Zitvogel,et al.  Mouse models in oncoimmunology , 2016, Nature Reviews Cancer.

[25]  A. Schnieke,et al.  Pigs as models of human cancers. , 2016, Theriogenology.

[26]  R. Hruban,et al.  Surgical and molecular pathology of pancreatic neoplasms , 2016, Diagnostic Pathology.

[27]  D. Largaespada,et al.  Engineered Swine Models of Cancer , 2016, Front. Genet..

[28]  D. Saur,et al.  A porcine model of osteosarcoma , 2016, Oncogenesis.

[29]  R. Gibbs,et al.  Genomic analyses identify molecular subtypes of pancreatic cancer , 2016, Nature.

[30]  P. Hertzog,et al.  Optimizing mouse models for precision cancer prevention , 2016, Nature Reviews Cancer.

[31]  D. Ayares,et al.  The role of genetically engineered pigs in xenotransplantation research , 2016, The Journal of pathology.

[32]  R. Coronel,et al.  Concise Review: Pluripotent Stem Cell‐Derived Cardiac Cells, A Promising Cell Source for Therapy of Heart Failure: Where Do We Stand? , 2016, Stem cells.

[33]  G. Church,et al.  Supplementary Materials for Genome-wide inactivation of porcine endogenous retroviruses ( PERVs ) , 2015 .

[34]  Martien A. M. Groenen,et al.  Adult porcine genome-wide DNA methylation patterns support pigs as a biomedical model , 2015, BMC Genomics.

[35]  Chi-Ping Day,et al.  Preclinical Mouse Cancer Models: A Maze of Opportunities and Challenges , 2015, Cell.

[36]  R. DePinho,et al.  Genetics and biology of pancreatic ductal adenocarcinoma. , 2006, Genes & development.

[37]  R. Prather,et al.  A Genetic Porcine Model of Cancer , 2015, PloS one.

[38]  Hyun Ji Kim,et al.  Phosphorylation and Reorganization of Keratin Networks: Implications for Carcinogenesis and Epithelial Mesenchymal Transition , 2015, Biomolecules & therapeutics.

[39]  J. Kench,et al.  Whole genomes redefine the mutational landscape of pancreatic cancer , 2015, Nature.

[40]  K. Schachtschneider,et al.  Unraveling the swine genome: implications for human health. , 2015, Annual review of animal biosciences.

[41]  W. Kues,et al.  Current Progress of Genetically Engineered Pig Models for Biomedical Research , 2014, BioResearch open access.

[42]  Joana A. Vidigal,et al.  In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system , 2014, Nature.

[43]  Francisco J. Sánchez-Rivera,et al.  Rapid modeling of cooperating genetic events in cancer through somatic genome editing , 2014, Nature.

[44]  D. Meyerholz,et al.  Development and translational imaging of a TP53 porcine tumorigenesis model. , 2014, The Journal of clinical investigation.

[45]  Benjamin J. Raphael,et al.  Mutational landscape and significance across 12 major cancer types , 2013, Nature.

[46]  Sathish Kumar Mungamuri,et al.  p53-dependent gene repression through p21 is mediated by recruitment of E2F4 repression complexes , 2013, Oncogene.

[47]  Gerald C. Chu,et al.  Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee. , 2013, Cancer research.

[48]  L. Schook,et al.  Abstract 1573: An inducible transgenic porcine model for human cancer. , 2013 .

[49]  K. Kinzler,et al.  Cancer Genome Landscapes , 2013, Science.

[50]  T. Miyakawa,et al.  Genomic responses in mouse models poorly mimic human inflammatory diseases , 2013 .

[51]  R. Prather,et al.  Genetically engineered pig models for human diseases. , 2013, Annual review of animal biosciences.

[52]  L. Lai,et al.  Genetically modified pig models for human diseases. , 2013, Journal of genetics and genomics = Yi chuan xue bao.

[53]  R. Gamelli,et al.  Genomic responses in mouse models poorly mimic human inflammatory diseases , 2013, Proceedings of the National Academy of Sciences.

[54]  P. Schirmacher,et al.  Epithelial-to-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma and Pancreatic Tumor Cell Lines: The Role of Neutrophils and Neutrophil-Derived Elastase , 2012, Clinical & developmental immunology.

[55]  E. Wolf,et al.  Completion of the swine genome will simplify the production of swine as a large animal biomedical model , 2012, BMC Medical Genomics.

[56]  E. Wolf,et al.  A porcine model of familial adenomatous polyposis. , 2012, Gastroenterology.

[57]  Bronwen L. Aken,et al.  Analyses of pig genomes provide insight into porcine demography and evolution , 2012, Nature.

[58]  E. Wolf,et al.  Inactivation and Inducible Oncogenic Mutation of p53 in Gene Targeted Pigs , 2012, PloS one.

[59]  Li Ding,et al.  Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers , 2012, Cell.

[60]  L. Bolund,et al.  Targeted genome editing by recombinant adeno-associated virus (rAAV) vectors for generating genetically modified pigs. , 2012, Journal of genetics and genomics = Yi chuan xue bao.

[61]  Mallika Singh,et al.  Genetically engineered mouse models: closing the gap between preclinical data and trial outcomes. , 2012, Cancer research.

[62]  L. Bolund,et al.  Pig gene knockout by rAAV-mediated homologous recombination: comparison of BRCA1 gene knockout efficiency in Yucatan and Göttingen fibroblasts with slightly different target sequences , 2012, Transgenic Research.

[63]  A. Børresen-Dale,et al.  The landscape of cancer genes and mutational processes in breast cancer , 2012, Nature.

[64]  M. Welsh,et al.  Reduced Airway Surface pH Impairs Bacterial Killing in the Porcine Cystic Fibrosis Lung , 2012, Nature.

[65]  I. Cuthill,et al.  Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research † , 2012, Osteoarthritis and cartilage.

[66]  C. Begley,et al.  Drug development: Raise standards for preclinical cancer research , 2012, Nature.

[67]  F. Clubb,et al.  Swine as Models in Biomedical Research and Toxicology Testing , 2012, Veterinary pathology.

[68]  Natalie Cook,et al.  Predictive in vivo animal models and translation to clinical trials. , 2012, Drug discovery today.

[69]  N. Ganderup,et al.  A Comparative Assessment of the Pig, Mouse and Human Genomes: Structural and Functional Analysis of Genes Involved in Immunity and Inammation , 2011 .

[70]  Hans Nauwynck,et al.  The pig: a model for human infectious diseases , 2011, Trends in Microbiology.

[71]  Huanming Yang,et al.  High efficiency of BRCA1 knockout using rAAV-mediated gene targeting: developing a pig model for breast cancer , 2011, Transgenic Research.

[72]  D. Hume,et al.  The mononuclear phagocyte system of the pig as a model for understanding human innate immunity and disease , 2011, Journal of leukocyte biology.

[73]  Liu Xiangdong,et al.  Animal models for the atherosclerosis research: a review , 2011, Protein & Cell.

[74]  R. Kerbel,et al.  Antiangiogenic therapy: impact on invasion, disease progression, and metastasis , 2011, Nature Reviews Clinical Oncology.

[75]  R. Kerbel,et al.  Mouse models of advanced spontaneous metastasis for experimental therapeutics , 2011, Nature Reviews Cancer.

[76]  Lawrence B. Schook,et al.  Pigs as a model for biomedical sciences. , 2011 .

[77]  I. Cuthill,et al.  Reporting : The ARRIVE Guidelines for Reporting Animal Research , 2010 .

[78]  L. Blackbourne,et al.  Safety evaluation of new hemostatic agents, smectite granules, and kaolin-coated gauze in a vascular injury wound model in swine. , 2010, The Journal of trauma.

[79]  T. Jacks,et al.  Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase , 2009, Nature Protocols.

[80]  G. Damiano,et al.  Isolation and culture of beta-like cells from porcine Wirsung duct. , 2009, Transplantation proceedings.

[81]  M. Bailey.  The mucosal immune system: recent developments and future directions in the pig. , 2009, Developmental and comparative immunology.

[82]  H. Rothkötter.  Anatomical particularities of the porcine immune system--a physician's view. , 2009, Developmental and comparative immunology.

[83]  H. Niemann,et al.  The perspectives for porcine-to-human xenografts. , 2009, Comparative immunology, microbiology and infectious diseases.

[84]  Thomas M Suszynski,et al.  Pig Pancreas Anatomy: Implications for Pancreas Procurement, Preservation, and Islet Isolation , 2008, Transplantation.

[85]  David K. Meyerholz,et al.  Disruption of the CFTR Gene Produces a Model of Cystic Fibrosis in Newborn Pigs , 2008, Science.

[86]  M. Spurlock,et al.  The development of porcine models of obesity and the metabolic syndrome. , 2008, The Journal of nutrition.

[87]  J. E. Kranz,et al.  Design, power, and interpretation of studies in the standard murine model of ALS , 2008, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[88]  Eva Forssell-Aronsson,et al.  Specific growth rate versus doubling time for quantitative characterization of tumor growth rate. , 2007, Cancer research.

[89]  I. Fidler,et al.  Murine models to evaluate novel and conventional therapeutic strategies for cancer. , 2007, The American journal of pathology.

[90]  J. Zachary,et al.  Genetic induction of tumorigenesis in Swine , 2007, Oncogene.

[91]  Ronald A. DePinho,et al.  Model organisms: The mighty mouse: genetically engineered mouse models in cancer drug development , 2006, Nature Reviews Drug Discovery.

[92]  P. Singh,et al.  RNA Interference Suppression of MUC1 Reduces the Growth Rate and Metastatic Phenotype of Human Pancreatic Cancer Cells , 2006, Clinical Cancer Research.

[93]  G. Donnan,et al.  1,026 Experimental treatments in acute stroke , 2006, Annals of neurology.

[94]  K. Smetana,et al.  The Miniature Pig as an Animal Model in Biomedical Research , 2005, Annals of the New York Academy of Sciences.

[95]  R. Hruban,et al.  Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. , 2005, Cancer cell.

[96]  Richard D Emes,et al.  Comparison of the genomes of human and mouse lays the foundation of genome zoology. , 2003, Human molecular genetics.

[97]  M. Löhr,et al.  Immortalized bovine pancreatic duct cells become tumorigenic after transfection with mutant k-ras , 2001, Virchows Archiv.

[98]  W. Eaglstein,et al.  THE PIG AS A MODEL FOR HUMAN WOUND HEALING , 2001, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[99]  S. Schmutz.  Genetics of the Pig , 2000, Nature.

[100]  S. Lukyanov,et al.  Fluorescent proteins from nonbioluminescent Anthozoa species , 1999, Nature Biotechnology.

[101]  M. Carlson,et al.  Release of mechanical tension triggers apoptosis of human fibroblasts in a model of regressing granulation tissue. , 1999, Experimental cell research.

[102]  Division on Earth.  Guide for the Care and Use of Laboratory Animals , 1996 .

[103]  N. Lemoine,et al.  Loss of membranous E‐cadherin expression in pancreatic cancer: Correlation with lymph node metastasis, high grade, and advanced stage , 1994, The Journal of pathology.

[104]  P. Friedman,et al.  Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53. , 1992, Genes & development.

[105]  L. Montagnier,et al.  AGAR SUSPENSION CULTURE FOR THE SELECTIVE ASSAY OF CELLS TRANSFORMED BY POLYOMA VIRUS. , 1964, Virology.

[106]  A. Scarpa,et al.  Pancreatic Cancer Genomics , 2013 .

[107]  Janice M. Reichert,et al.  Development trends for new cancer therapeutics and vaccines. , 2008, Drug discovery today.

[108]  M. Swindle,et al.  Swine in the laboratory: surgery, anesthesia, imaging, and experimental techniques , 2007 .